Patrick Rossignol
#148,385
Most Influential Person Now
Researcher
Patrick Rossignol's AcademicInfluence.com Rankings
Patrick Rossignolcomputer-science Degrees
Computer Science
#7626
World Rank
#8028
Historical Rank
Computational Linguistics
#1555
World Rank
#1572
Historical Rank
Machine Learning
#2876
World Rank
#2912
Historical Rank
Artificial Intelligence
#3170
World Rank
#3217
Historical Rank
Download Badge
Computer Science
Patrick Rossignol's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Patrick Rossignol Influential?
(Suggest an Edit or Addition)Patrick Rossignol's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19 (2020) (1744)
- The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology (2019) (459)
- Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (328)
- Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. (2002) (325)
- Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis (2013) (309)
- Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study (2009) (252)
- Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study. (2015) (227)
- Vascular Structure and Function Is Correlated to Cognitive Performance and White Matter Hyperintensities in Older Hypertensive Patients With Subjective Memory Complaints (2009) (224)
- The systemic nature of CKD (2017) (218)
- Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. (2018) (217)
- Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). (2012) (213)
- Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF (Cardiac Resynchronization in Heart Failure) trial (2012) (209)
- Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). (2013) (201)
- Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure (2015) (191)
- Heart failure drug treatment (2019) (190)
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial (2019) (179)
- The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. (2015) (174)
- Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. (2012) (163)
- Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. (2006) (159)
- Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist (2014) (158)
- Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2018) (158)
- Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology (2018) (155)
- Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology (2020) (145)
- Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction: Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (2012) (140)
- The double challenge of resistant hypertension and chronic kidney disease (2015) (134)
- Porphyromonas gingivalis Participates in Pathogenesis of Human Abdominal Aortic Aneurysm by Neutrophil Activation. Proof of Concept in Rats (2011) (132)
- Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. (2017) (128)
- Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension (2015) (126)
- Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians. (2015) (122)
- Mediators of neutrophil recruitment in human abdominal aortic aneurysms (2009) (120)
- Lipid management in patients with chronic kidney disease (2018) (119)
- Decongestion in acute heart failure (2014) (115)
- The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study. (2016) (114)
- Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality (2017) (111)
- Cardiorenal Syndrome Revisited (2018) (109)
- Pulse Wave Velocity Assessment by External Noninvasive Devices and Phase-Contrast Magnetic Resonance Imaging in the Obese (2009) (106)
- Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trials (2015) (105)
- Protease Nexin-1 Inhibits Plasminogen Activation-induced Apoptosis of Adherent Cells* (2004) (101)
- HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property (2009) (100)
- Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion (2018) (97)
- Blood pressure and renal outcomes in patients with kidney infarction and hypertension (2006) (95)
- Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference (2017) (94)
- Tubular damage and worsening renal function in chronic heart failure. (2013) (94)
- Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future (2017) (93)
- Prognostic Value of Estimated Plasma Volume in Heart Failure. (2015) (91)
- Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. (2016) (89)
- Extracellular matrix fibrotic markers in heart failure (2010) (87)
- Visit-to-Visit Blood Pressure Variability Is a Strong Predictor of Cardiovascular Events in Hemodialysis: Insights From FOSIDIAL (2012) (86)
- Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2020) (84)
- Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (84)
- Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. (2008) (81)
- Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial (2017) (80)
- Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT‐CHF (2017) (77)
- Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative (2015) (76)
- Opposite Predictive Value of Pulse Pressure and Aortic Pulse Wave Velocity on Heart Failure With Reduced Left Ventricular Ejection Fraction: Insights From an Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Substudy (2014) (74)
- Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase (2015) (73)
- Renin–Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data (2017) (72)
- Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity (2015) (72)
- Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles (2016) (71)
- Reduced Immunoregulatory CD31+ T Cells in Patients With Atherosclerotic Abdominal Aortic Aneurysm (2005) (70)
- Neutrophil Gelatinase-Associated Lipocalin Is a Novel Mineralocorticoid Target in the Cardiovascular System (2012) (69)
- Neutrophil Gelatinase–Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids (2015) (69)
- Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review. (2020) (69)
- Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry (2020) (67)
- Clinical management of the uraemic syndrome in chronic kidney disease. (2016) (67)
- Cardiotrophin 1 Is Involved in Cardiac, Vascular, and Renal Fibrosis and Dysfunction (2012) (67)
- Compliance of abdominal aortic aneurysms evaluated by tissue Doppler imaging: correlation with aneurysm size. (2005) (67)
- Management of hyperkalemia in the acutely ill patient (2019) (65)
- Intima–Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population‐Based Cohort (STANISLAS Cohort Study) (2016) (63)
- Geographic differences in heart failure trials (2015) (62)
- Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. (2011) (61)
- Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis. (2014) (60)
- Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. (2007) (60)
- Features of Cardiac Remodeling, Associated With Blood Pressure and Fibrosis Biomarkers, Are Frequent in Subjects With Abdominal Obesity (2014) (60)
- A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. (2011) (60)
- Cardiovascular Consequences of Acute Kidney Injury. (2020) (60)
- Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT‐CHF (2018) (58)
- The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial (2020) (57)
- Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. (2019) (57)
- Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial. (2013) (57)
- Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring Methods, Thresholds, and Patterns (2016) (55)
- Role for Galectin‐3 in Calcific Aortic Valve Stenosis (2016) (55)
- Aldosterone Target NGAL (Neutrophil Gelatinase–Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NF&kgr;B Pathway (2017) (53)
- Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies (2020) (52)
- Spontaneous renal artery dissection: long-term outcomes after endovascular stent placement. (2009) (51)
- Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project. (2016) (51)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- Circulating Osteoglycin and NGAL/MMP9 Complex Concentrations Predict 1-Year Major Adverse Cardiovascular Events After Coronary Angiography (2014) (49)
- Compliance of abdominal aortic aneurysms: evaluation of tissue Doppler imaging. (2004) (49)
- Short Telomeres, but Not Telomere Attrition Rates, Are Associated With Carotid Atherosclerosis (2017) (48)
- Impact of Changes in Consensus Diagnostic Recommendations on the Echocardiographic Prevalence of Diastolic Dysfunction. (2017) (48)
- Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (2020) (47)
- Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques (2006) (46)
- Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis (2016) (46)
- Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure. (2019) (44)
- Accuracy of Several Lung Ultrasound Methods for the Diagnosis of Acute Heart Failure in the ED (2019) (43)
- Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease (2018) (43)
- Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints (2019) (43)
- Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial (2020) (43)
- Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial (2019) (42)
- Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives (2016) (42)
- Neutrophil Gelatinase-Associated Lipocalin from immune cells is mandatory for aldosterone-induced cardiac remodeling and inflammation. (2018) (42)
- Blunt renal trauma-induced hypertension: prevalence, presentation, and outcome. (2006) (42)
- A Role for Soluble ST2 in Vascular Remodeling Associated with Obesity in Rats (2013) (41)
- Galectin-3 inhibition prevents adipose tissue remodelling in obesity (2016) (41)
- The Serpin Protease-Nexin 1 Is Present in Rat Aortic Smooth Muscle Cells and Is Upregulated in l-NAME Hypertensive Rats (2003) (41)
- Absence of Cardiotrophin 1 Is Associated With Decreased Age-Dependent Arterial Stiffness and Increased Longevity in Mice (2013) (41)
- Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study (2016) (41)
- Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage (2016) (40)
- Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes (2012) (39)
- Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial). (2015) (39)
- Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm. (2013) (38)
- Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative (2017) (37)
- Race Influences the Safety and Efficacy of Spironolactone in Severe Heart Failure (2013) (36)
- Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia (2017) (36)
- Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction (2020) (36)
- Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference (2020) (35)
- Prognostic value of estimated plasma volume in acute heart failure in three cohort studies (2018) (35)
- Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis (2016) (35)
- Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS. (2012) (35)
- Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease: Time for Action. (2017) (35)
- Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect (2016) (34)
- Reproducibility in Echocardiographic Assessment of Diastolic Function in a Population Based Study (The STANISLAS Cohort Study) (2015) (34)
- Influence of the recommendations on the implementation of home blood pressure measurement by French general practitioners: a 2004–2009 longitudinal survey (2011) (33)
- Hemorphin 7 Reflects Hemoglobin Proteolysis in Abdominal Aortic Aneurysm (2010) (33)
- Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage. (2018) (32)
- Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation (2015) (31)
- Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. (2018) (31)
- Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF. (2020) (31)
- Extracellular Matrix Turnover Biomarkers Predict Long-Term Left Ventricular Remodeling After Myocardial Infarction: Insights From the REVE-2 Study (2013) (31)
- Emerging Drug Classes and Their Potential Use in Hypertension. (2019) (30)
- Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: insights from the HEAAL study. (2014) (30)
- Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial. (2020) (30)
- A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis (2016) (30)
- SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE) (2014) (30)
- Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort (2018) (29)
- Association of beta‐blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched‐cohort analysis from the High‐Risk Myocardial Infarction Database Initiative (2017) (29)
- Telomere length tracking in children and their parents: implications for adult onset diseases (2019) (29)
- Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension) (2017) (29)
- A multifactorial strategy of pain management is associated with less pain in scheduled vaccination of children. A study realized by family practitioners in 239 children aged 4-12 years old. (2008) (28)
- Serum potassium in the PARADIGM‐HF trial (2020) (28)
- Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications (2018) (28)
- Vascular effects of cardiotrophin-1: a role in hypertension? (2010) (28)
- Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial (2017) (28)
- A randomized multicenter trial on a lung ultrasound guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk. (2021) (28)
- Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial (2017) (28)
- Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis. (2014) (27)
- Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts (2017) (26)
- Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study. (2015) (26)
- Saliva as a medium for aldosterone measurement in repeated sampling studies (2009) (26)
- Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia. (2017) (26)
- Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats (2018) (26)
- Urinary peptides in heart failure: a link to molecular pathophysiology (2021) (25)
- Evidence of Cyclic Changes in the Metabolism of Abdominal Aortic Aneurysms During Growth Phases: 18F-FDG PET Sequential Observational Study (2015) (25)
- Changes in Urinary Total Metanephrine Excretion in Recurrent and Malignant Pheochromocytomas and Secreting Paragangliomas (2006) (25)
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022) (25)
- A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. (2004) (25)
- Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation. (2018) (25)
- NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4. (2016) (25)
- Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Effic (2017) (25)
- MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT. (2019) (25)
- Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure (2018) (24)
- Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey (2017) (24)
- Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west. (2015) (24)
- Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study (2017) (24)
- Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction (2018) (24)
- High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (24)
- Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study. (2017) (24)
- Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial (2021) (23)
- Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis (2017) (22)
- The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward. (2019) (22)
- Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT (2020) (22)
- Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns (2018) (22)
- Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research. (2015) (22)
- Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology (2022) (21)
- Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials (2020) (21)
- Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study (2018) (21)
- Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints (2010) (21)
- New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval. (2016) (21)
- Comprehensive MRI analysis of early cardiac and vascular remodeling in middle-aged patients with abdominal obesity (2012) (21)
- Plasminogen activator inhibitor-1 impairs plasminogen activationmediated vascular smooth muscle cell apoptosis (2006) (21)
- Differentiated thick ascending limb (TAL) cultured cells derived from SV40 transgenic mice express functional apical NHE2 isoform: effect of nitric oxide (2003) (21)
- Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial (2020) (21)
- Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension (2017) (21)
- Reproducibility of echocardiographic assessment of 2D-derived longitudinal strain parameters in a population-based study (the STANISLAS Cohort study) (2017) (20)
- Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases (2013) (20)
- Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not? (2017) (20)
- Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries. (2014) (20)
- Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. (2018) (20)
- Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure. (2015) (20)
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre‐specified subgroup with heart failure (2020) (19)
- Optimization of in vitro vascular cell transfection with non‐viral vectors for in vivo applications (2004) (19)
- Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative (2019) (19)
- Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure) (2020) (19)
- Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non‐sudden cardiac death in myocardial infarction survivors with heart failure (2019) (19)
- Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction (2020) (18)
- Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. (2021) (18)
- A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis. (2017) (18)
- Effectiveness of a multidisciplinary heart failure disease management programme on 1-year mortality (2016) (18)
- Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach (2020) (18)
- Head-to-head comparison of clustering methods for heterogeneous data: a simulation-driven benchmark (2021) (18)
- Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without (2019) (18)
- Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case–control analyses (2019) (18)
- Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial. (2022) (18)
- Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size (2002) (18)
- Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022) (18)
- INFLUENCE OF BLOOD SAMPLING PROCEDURE ON PLASMA CONCENTRATIONS OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS (2008) (18)
- Temporal deformation pattern in acute and late phases of ST-elevation myocardial infarction: incremental value of longitudinal post-systolic strain to assess myocardial viability (2016) (17)
- Income level and inequality as complement to geographical differences in cardiovascular trials. (2019) (17)
- Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure. (2019) (17)
- Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies (2020) (17)
- Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study (2017) (17)
- Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction (2020) (17)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- Accuracy of several lung ultrasound methods for the diagnosis of acute heart failure in the emergency department: A multicenter prospective study. (2019) (17)
- Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model (2017) (17)
- Association between mean systolic and diastolic blood pressure throughout the follow‐up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High‐Risk Myocardial Infarction Database Initiative (2018) (17)
- Machine Learning-Derived Echocardiographic Phenotypes Predict Heart Failure Incidence in Asymptomatic Individuals. (2021) (16)
- Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations (2018) (16)
- The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients (2017) (16)
- Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction. (2019) (16)
- Coronary angiography in worsening heart failure: determinants, findings and prognostic implications (2017) (16)
- Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension (2017) (16)
- Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial (2020) (16)
- Roadmap for cardiovascular prevention trials in chronic kidney disease (2016) (15)
- Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies (2020) (15)
- Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1 (2020) (15)
- A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts. (2018) (15)
- Heart failure with preserved ejection fraction: a nephrologist-directed primer (2017) (15)
- Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study). (2019) (15)
- Estimated plasma volume status in heart failure: clinical implications and future directions (2021) (15)
- Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration (2016) (15)
- Abstract 9925: Association between Resting Heart Rate, Chronotropic Index and Long-term Outcomes in Patients with Heart Failure Receiving Beta-blocker Therapy. Data from the HF-ACTION Trial (2012) (14)
- Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial (2019) (14)
- Neural modulation for hypertension and heart failure. (2016) (14)
- Predictors of sudden cardiac death in high‐risk patients following a myocardial infarction (2020) (14)
- Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial (2013) (14)
- Left ventricular myocardial deformation pattern, mechanical dispersion, and their relation with electrocardiogram markers in the large population-based STANISLAS cohort: insights into electromechanical coupling. (2020) (14)
- Association of estimated plasma volume status with hemodynamic and echocardiographic parameters (2020) (14)
- Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: An in vitro and in vivo study in aortic stenosis. (2019) (14)
- Effect of Coffee Consumption on Renal Outcome: A Systematic Review and Meta-Analysis of Clinical Studies. (2020) (14)
- Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial) (2019) (13)
- CALCIUM CHANNEL BLOCKERS USE IS ASSOCIATED WITH A BETTER COGNITIVE PERFORMANCE IN OLDER HYPERTENSIVE PATIENTS WITH SUBJECTIVE MEMORY COMPLAINTS: 9D.07 (2010) (13)
- Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study (2013) (13)
- Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics (2021) (13)
- Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology. (2020) (13)
- Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage. (2021) (13)
- Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisal (2017) (13)
- Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (13)
- Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction (2017) (13)
- Low fibrosis biomarker levels predict cardiac resynchronization therapy response (2019) (12)
- Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. (2019) (12)
- Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality (2016) (12)
- The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure (2016) (12)
- Longer Duration of Hypertension and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension (2020) (12)
- Association Study of Gene Polymorphisms Involved in Vascular Alterations in Elderly Hypertensives with Subjective Memory Complaints (2010) (12)
- Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism (2015) (12)
- Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go? (2017) (12)
- Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study. (2020) (12)
- Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials. (2016) (12)
- Editor’s Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction (2018) (12)
- Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up. (2020) (12)
- Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort. (2019) (11)
- Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids (2020) (11)
- Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension (2021) (11)
- The association between serum potassium and mortality in patients with hypertension: ‘a wake-up call’ (2016) (11)
- Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial. (2020) (11)
- Hyponatraemia, hyperglycaemia and worsening renal function at first blood sample on emergency department admission as predictors of in-hospital death in patients with dyspnoea with suspected acute heart failure: retrospective observational analysis of the PARADISE cohort (2018) (11)
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology (2022) (11)
- Low baseline and subsequent higher aortic abdominal aneurysm FDG uptake are associated with poor sac shrinkage post endovascular repair (2018) (11)
- Can we prevent or treat renal dysfunction in chronic heart failure? (2012) (11)
- Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis. (2016) (11)
- Optimizing hypertension management in renal transplantation: a call to action. (2017) (11)
- Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled tria (2013) (11)
- Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score (2021) (10)
- A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology (2019) (10)
- [Hypertension in the elderly]. (2006) (10)
- Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging. (2016) (10)
- Reduced Diuretic Dose in Patients Treated With Eplerenone (2020) (10)
- Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models (2021) (10)
- Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort (2018) (10)
- Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure. (2018) (10)
- Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review (2019) (10)
- Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes. (2019) (10)
- Optimizing hypertension management in renal transplantation: a call to action. (2017) (10)
- Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein (2021) (10)
- Loop diuretics and ultrafiltration in heart failure (2013) (10)
- Reduced Immunoregulatory CD 31 T Cells in Patients With Atherosclerotic Abdominal Aortic Aneurysm (2005) (10)
- Evaluation of Subclinical Fluid Overload Using Lung Ultrasound and Estimated Plasma Volume in the Postoperative Period Following Kidney Transplantation. (2018) (10)
- Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (10)
- Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative). (2018) (10)
- A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse (2020) (10)
- Renal function, electrolytes, and congestion monitoring in heart failure (2019) (10)
- Adherence to ESC guideline‐recommended medications over a 36‐month follow‐up period after hospitalization for heart failure: Results from the EPICAL2 cohort study (2019) (9)
- Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study. (2019) (9)
- Sex differences in circulating proteins in heart failure with preserved ejection fraction (2020) (9)
- Health-related determinants of undiagnosed arterial hypertension: a population-based study. (2018) (9)
- Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients! (2015) (9)
- Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program (2021) (9)
- Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial (2019) (9)
- Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study. (2020) (9)
- Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure: Regression to the Truth? (2019) (9)
- Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE) (2022) (8)
- Practical management of concomitant acute heart failure and worsening renal function in the emergency department (2017) (8)
- Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial) (2019) (8)
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial (2020) (8)
- Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial). (2016) (8)
- The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure (2021) (8)
- EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial (2018) (8)
- PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle‐Aged Population: The STANISLAS Cohort (2020) (8)
- The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial (2022) (8)
- Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort (2018) (8)
- Impact of the interruption of a large heart failure regional disease management programme on hospital admission rates: a population‐based study (2018) (8)
- Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy (2021) (8)
- Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge (2020) (8)
- Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials (2018) (8)
- Targeting the aldosterone pathway in cardiovascular disease (2012) (8)
- Individualizing treatment choices in the systolic blood pressure intervention trial (2018) (8)
- Home blood pressure monitoring: a few minutes of rest before measurement may not be appropriate. (2014) (7)
- Association of Dietary Patterns Derived Using Reduced‐Rank Regression With Subclinical Cardiovascular Damage According to Generation and Sex in the STANISLAS Cohort (2020) (7)
- Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease. (2021) (7)
- Circulating multimarker approach to identify patients with preclinical left ventricular remodelling and/or diastolic dysfunction (2021) (7)
- Diagnostic performance of congestion score index evaluated from chest radiography for acute heart failure in the emergency department: A retrospective analysis from the PARADISE cohort (2020) (7)
- Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis (2017) (7)
- Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative (2017) (7)
- Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (2021) (7)
- Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial. (2020) (7)
- Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial (2020) (7)
- [Arterial hypertension secondary to curable causes in adults]. (2002) (7)
- Mineralocorticoid Receptor Antagonists in High‐Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease (2017) (7)
- Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study (2020) (7)
- Salivary aldosterone as a diagnostic aid in primary aldosteronism. (2010) (7)
- Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database). (2018) (7)
- Optimizing the Design and Analysis of Future AKI Trials. (2022) (7)
- Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence (2016) (7)
- Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure (2020) (7)
- Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells (2005) (6)
- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction (2018) (6)
- Overcoming barriers in the design and implementation of clinical trials for Acute Kidney Injury: a report from the 2020 Kidney Disease Clinical Trialists meeting. (2022) (6)
- Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction (2022) (6)
- [Physiopathology of aortic aneurysm]. (2002) (6)
- Incidence , Predictors and Outcomes Related to Hypo and Hyperkalemia in Severe Heart Failure Patients Treated with a Mineralocorticoid Receptor Antagonist (2014) (6)
- Estimated Long-Term Survival With Eplerenone. (2019) (6)
- Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD. (2022) (6)
- Telemedicine: what framework, what levels of proof, implementation rules. (2014) (6)
- Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes: Data From the MIRAD Trial. (2021) (6)
- The unit of Estimated Plasma Volume in Patients with Heart Failure using the Strauss-derived Duarte formula is not liter but dL/g. (2019) (6)
- Impact of Geographic Region on the COMMANDER-HF Trial. (2020) (6)
- Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003–2017 (2021) (6)
- Performing lung ultrasound at rest and/or after an exercise stress test to better identify high‐risk ambulatory patients with heart failure (2017) (6)
- Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial (2022) (5)
- Renin-angiotensin-aldosterone system and kidney interactions in heart failure (2019) (5)
- Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial (2021) (5)
- Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis (2021) (5)
- Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer (2020) (5)
- Reproducibility in Echotracking Assessment of Local Carotid Stiffness, Diameter and Thickness in a Population-based Study (The STANISLAS Cohort Study) (2020) (5)
- Practical outpatient management of worsening chronic heart failure (2022) (5)
- Mineralocorticoid Receptor Antagonists and SGLT2 Inhibitor Therapy: The Best of Both Worlds in HFrEF. (2021) (5)
- Association Between Layer-Specific Longitudinal Strain and Risk Factors of Heart Failure and Dyspnea: A Population-Based Study. (2019) (5)
- Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2. (2007) (5)
- Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial (2021) (5)
- Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus. (2020) (5)
- Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial (2021) (5)
- Circulating plasma proteins and new-onset diabetes in a population-based study: proteomic and genomic insights from the STANISLAS cohort. (2020) (5)
- Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial (2021) (5)
- Kidney disease 1 Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (4)
- Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients (2020) (4)
- Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings (2018) (4)
- Maintenance of a Computerized Medical Record Form (2007) (4)
- Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials (2022) (4)
- Male Sex Is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia (2021) (4)
- Left-to-right atrial shunting: new hope for heart failure? (2016) (4)
- Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative. (2017) (4)
- Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial (2019) (4)
- Insulin-like growth factor binding protein 2: A prognostic biomarker for heart failure hardly redundant with natriuretic peptides. (2019) (4)
- Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC–WHO clinical characterisation protocol (2022) (4)
- Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function (4)
- Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure (2020) (4)
- Poster session 2 (2004) (4)
- Temporal Trend and Time-Varying Effect of Preemptive Second Kidney Transplantation on Graft Survival: A 30-Year Single-Center Cohort Study. (2016) (4)
- Isolated diastolic hypertension and target organ damage: Findings from the STANISLAS cohort (2021) (4)
- Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure (2022) (4)
- Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction. (2021) (4)
- Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical Trials. (2021) (4)
- SELECTION OF PATIENTS FOR SURGERY FOR PRIMARY ALDOSTERONISM (2008) (4)
- Hypokalemia is frequent and has prognostic implications in stable patients attending the emergency department (2020) (4)
- A man with proteinuria, familial history of kidney disease, painful extremities and cutaneous lesions. (2000) (4)
- Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. (2021) (4)
- Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial. (2021) (4)
- Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views. (2019) (4)
- Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial (2018) (4)
- Identification of sex‐specific biomarkers predicting new‐onset heart failure (2021) (4)
- Echocardiographic diastolic function evolution in patients with an anterior Q‐wave myocardial infarction: insights from the REVE‐2 study (2018) (3)
- Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort. (2022) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- Hyperkalaemia and hypokalaemia outpatient management: a survey of 500 French general practitioners (2020) (3)
- Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap". (2018) (3)
- Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults (2022) (3)
- Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring! (2019) (3)
- Correlation of Quantitated Intravascular Volume with Blood Pressure in Patients with Systemic Hypertension (2019) (3)
- Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. (2019) (3)
- A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease (2022) (3)
- Nuclear cardiology bullet Inflammatory F-18 fluorodeoxyglucose uptake over arterial bypass prosthesis seen on positron emission tomography can predict acute vascular events (2006) (3)
- A RANDOMIZED CONTROLLED MULTICENTER TRIAL OF A HEPARIN-GRAFTED POLYACRYLONITRILE MEMBRANE FOR NO-HEPARIN HEMODIALYSIS VERSUS STANDARD-OF-CARE : RESULTS OF THE HEPZERO STUDY (2014) (3)
- Monday, 27 August 2012 (2012) (3)
- Intravenous Mineralocorticoid Receptor Antagonist Use in Acutely Decompensated Heart Failure with Diuretic Resistance. (2021) (3)
- Personalized ultrafiltration for worsening heart failure: is biological evaluation of plasma volume and lung ultrasound the answer? (2014) (3)
- H016 Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the ephesus study (2009) (3)
- Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis (2021) (3)
- Sarcopenia in patients after an episode of acute decompensated heart failure: An underdiagnosed problem with serious impact. (2021) (3)
- Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA) (2020) (3)
- The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe (2021) (3)
- The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial (2020) (3)
- Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial (2022) (3)
- The Mineralocorticoid Receptor Antagonist Eplerenone Suppress Interstitial Fibrosis in Subcutaneous Adipose Tissue in Type 2 Diabetes Patients. (2020) (3)
- Plasma Volume Status and its Association with In-Hospital and Post-Discharge Outcomes in Decompensated Heart Failure. (2020) (3)
- Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study (2020) (2)
- Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study (2020) (2)
- Blood pressure reduction and anti‐hypertensive treatment choice: A post‐hoc analysis of the SPRINT trial (2021) (2)
- Poster Session 2 (2009) (2)
- Association between eating behaviour and 13-year cardiovascular damages in the initially healthy STANISLAS cohort. (2023) (2)
- Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial (2021) (2)
- Extracellular matrix turnover biomarkers predict left ventricular remodeling after myocardial infarction (insights from the REVE-2 study) (2013) (2)
- Incidence, Predictors and Outcomes Related to Hypo and Hyperkalemia in Severe Heart Failure Patients Treated With an Aldosterone Antagonist (2012) (2)
- Erratum: Polypharmacy in the aging patient: Management of hypertension in octogenarians (JAMA - Journal of the American Medical Association (2015) 314:2 (170-180)) (2015) (2)
- Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT (2021) (2)
- Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort (2021) (2)
- A Combination of Chest Radiography and Estimated Plasma Volume May Predict In-Hospital Mortality in Acute Heart Failure (2022) (2)
- Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study. (2019) (2)
- A review from the Biomarkers Working Group of the Heart Failure Association of the ESC: A review from the Biomarkers Working Group of the Heart Failure Association of the ESC. (2022) (2)
- Enlarging red blood cell distribution width during hospitalization identifies a very high-risk subset of acutely decompensated heart failure patients and adds valuable prognostic information on top of hemoconcentration: Erratum (2016) (2)
- Author Correction: Lipid management in patients with chronic kidney disease (2018) (2)
- The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease. (2022) (2)
- Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study (2022) (2)
- Prognosis of Advanced Heart Failure Patients according to Their Hemodynamic Profile Based on the Modified Forrester Classification (2022) (2)
- Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology (2022) (2)
- Stress myocardial perfusion gated-SPECT imaging in advanced chronic kidney disease (2018) (2)
- Association between Long-Term Change in Arterial Stiffness and Cardiovascular Outcomes in Kidney Transplant Recipients: Insights from the TRANSARTE Study (2022) (2)
- Statin therapy and clinical outcomes in acute heart failure patients complicating acute myocardial infarction : insights from the EPHESUS trial (2012) (2)
- Reply: Carbohydrate Antigen-125 in Heart Failure: An Overlooked Biomarker of Congestion. (2018) (2)
- 3C.07: ARE THE PHYSICIANS RELUCTANT TO PRACTICE TELEMEDICINE IN HYPERTENSION? (2015) (2)
- A Step Forward Toward a New Treatment Paradigm in the Cardiorenal Continuum. (2021) (2)
- Hypertension management in patients with cardiovascular comorbidities. (2022) (2)
- 2C.01: FIXED RANKING OF LEUKOCYTE TELOMERE LENGTH IN ELDERLY PEOPLE RESULTS FROM 8 YEAR FOLLOW-UP OF THE ADELAHYDE COHORT (2015) (2)
- Quality of Beverage Intake and Cardiometabolic and Kidney Outcomes: Insights From the STANISLAS Cohort (2022) (2)
- Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation (2017) (2)
- Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act. (2021) (1)
- HIPPOCAMPUS VOLUMETRY AND VASCULAR DAMAGE IN A COHORT OF OLDER PATIENTS WITH HYPERTENSION: INSIGHTS FROM THE ADELAHYDE STUDY (2018) (1)
- Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study) (2023) (1)
- Galectin-3 is a potential mediator of aldosterone effects in vascular remodeling (2011) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER). (2021) (1)
- Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review (2021) (1)
- Patiromer vs. Placebo to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in Prespecified Subgroups (2019) (1)
- EARLY AND LATE EFFECTS OF ANGIOTENSIN RECEPTOR BLOCKADE ON KIDNEY FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE (2012) (1)
- Handgrip strength to screen early-onset sarcopenia in heart failure. (2022) (1)
- Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction. (2022) (1)
- Hyperkalemia in the Emergency Department: Urgent Need for a Rigorous Evaluation of the First-Line Treatments. (2019) (1)
- Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database. (2020) (1)
- No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial (2021) (1)
- Calcium Channel Blockers Use is Associated with A Better Cognitive Performance in Older Hypertensive Patients with Subjective Memory Complaints (2010) (1)
- Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial (2022) (1)
- Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis. (2020) (1)
- Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients (2022) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- Arterial and Cardiac Remodeling Associated With Extra Weight Gain in an Isolated Abdominal Obesity Cohort (2021) (1)
- The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction (2020) (1)
- Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (2021) (1)
- [Carotid barostimulation in the treatment of resistant hypertension]. (2016) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial? (2019) (1)
- High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study. (2022) (1)
- Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial (2021) (1)
- Fatty acid desaturase genetic variations and dietary omega-3 fatty acid intake associate with arterial stiffness (2022) (1)
- Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial (2021) (1)
- Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank (2022) (1)
- Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients (2022) (1)
- Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study (2022) (1)
- Potassium management with finerenone: Practical aspects (2022) (1)
- Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches (2020) (1)
- Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the High-Risk-Myocardial-Infarction database (2020) (1)
- P4392Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status (2017) (1)
- Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort. (2021) (1)
- Corrigendum: Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study (2017) (1)
- Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study (2017) (1)
- Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction (2021) (1)
- Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials. (2023) (1)
- Impact of anti-hypertensive therapy in the sexual health of men and women: an analysis from the SPRINT trial. (2021) (1)
- Haemodynamic parameters associated with renal function prior to and following heart transplantation (2021) (1)
- Prognostic relevance of magnesium alterations in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial. (2022) (1)
- Dosing of losartan in men vs. women with HFrEF: the HEAAL trial. (2021) (1)
- Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation (2022) (1)
- Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial (2021) (1)
- Spironolactone for resistant hypertension in advanced chronic kidney disease-red, amber or green? (2020) (1)
- Reduction In body weight is an independent risk factor for mortality in chronic heart failure. Insights from GISSI-HF and Val-HeFT trials (2013) (1)
- [PP.10.08] PRESENCE OF AORTIC ABDOMINAL CALCIFICATIONS IN PATIENTS WITH RESISTANT HYPERTENSION AND BP RESPONSE IN THE RENAL DENERVATION FOR HYPERTENSION (DENERHTN) TRIAL (2016) (1)
- 0096 : Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase (2015) (1)
- Pragmatic Diagnostic and Therapeutic Algorithms to Optimize New Potassium Binder use in Cardiorenal Disease. (2022) (1)
- Correction: Diagnostic performance of congestion score index evaluated from chest radiography for acute heart failure in the emergency department: A retrospective analysis from the PARADISE cohort (2021) (1)
- Cardiac Remodeling and Diastolic Dysfunction in Paroxysmal Atrial Fibrillation (2021) (1)
- Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalemia: Co-001 (2016) (1)
- Metabolic Syndrome and the Risk of Preclinical Heart Failure: Insights after 17 Years of Follow-Up from the STANISLAS Cohort (2022) (1)
- Heart Failure Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction (2012) (1)
- Significant Long-term Variations in Left Ventricular Ejection Fraction Driven by Systemic Vascular Resistance Changes (2021) (0)
- INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY (2012) (0)
- Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). (2023) (0)
- POOR ADHERENCE TO BLOOD PRESSURE MEASUREMENT RECOMMENDATIONS IN EUROPEAN DIALYSIS CENTERS (2018) (0)
- Is it time to shift our focus from treatment to prevention of heart failure with a mineralocorticoid receptor antagonist? (2022) (0)
- Relationship Between Left Ventricular Ejection Fraction Variation and Systemic Vascular Resistance: A Prospective Cardiovascular Magnetic Resonance Study (2021) (0)
- Dyskalemia: a management problem for students (2020) (0)
- P6.04: COMPARISON BETWEEN PULSE WAVE VELOCITY ASSESSMENT IN THE OBESE BY TRANSCUTANEOUS DEVICES COMPARED TO PHASE CONTRAST MAGNETIC RESONANCE IMAGING (0)
- Cardiovascular Consequences of Acute Kidney Injury. Reply. (2020) (0)
- 3.4: INSTANTANEOUS BLOOD PRESSURE IS A DETERMINANT OF AORTIC AUGMENTATION INDEX AND PULSE WAVE VELOCITY: OBSERVATIONS IN PATIENTS WITH AUTONOMIC FAILURE PRESSURE IS A DETERMINANT OF AUGMENTATION WAVE VELOCITY: OBSERVATIONS IN PATIENTS WITH AUTONOMIC (0)
- 1181-P: Effect and Feasibility of High Dose Eplerenone in Type 2 Diabetes: A Mirad Substudy (2019) (0)
- On the effect of pressure variation on mortality and morbidity in patients with analysis. (2011) (0)
- ANTIPLATELET AND ANTICOAGULANT THERAPY DURING ANGIOPLASTY PROCEDURES FOR ATHEROMATOUS OR FIBROMUSCULAR DYSPLASIA RENAL ARTERY STENOSIS: A SURVEY OF PRACTICES IN EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (ESH-EC) IN FRANCE (2022) (0)
- Should renin angiotensin aldosterone system inhibition enablement be a therapeutic target in CKD patients? (2021) (0)
- infarctionserum collagen markers after acute myocardial Atrial natriuretic peptide, B-type natriuretic peptide, (2015) (0)
- Defining Myocardial Infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group. (2023) (0)
- PP.41.30: CLINICAL AND BIOLOGICAL ASSOCIATED FACTORS WITH ELEVATED ANKLE BRACHIAL INDEX IN GENERAL PRACTICE (2015) (0)
- Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts (2017) (0)
- CARDIOTROPHIN-1 IS A NEW KEY PLAYER IN CARDIAC AND VASCULAR FIBROSIS AND IN CARDIOVASCULAR DYSFUNCTION BEYOND HYPERTENSION: 3D.03 (2011) (0)
- Front & Back Matter (2014) (0)
- Olivier, A. et al. (2017) Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: insight from the EMPHASIS-HF trial. European Journal of Heart (2018) (0)
- Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20‐Year Follow‐Up (2022) (0)
- Fibrinolysis for intermediate-risk pulmonary embolism. (2014) (0)
- 411 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IS A NOVEL MINERALOCORTICOID TARGET IN THE CARDIOVASCULAR SYSTEM (2012) (0)
- Sarcopenia represents a very frequent comorbity in TAVI patients (2020) (0)
- Abstract 15368: Prognostic Value Of Inflammatory, Extracellular Matrix And Necrosis Biomarkers, And Their Relationship With Neurohormonal Biomarkers And Outcome In Patients With Acute Heart Failure. Data From The Everest Trial (2011) (0)
- [Influence of recent trials on essential arterial hypertension management]. (2004) (0)
- 0226 : Neutrophil gelatinase – associated lipocalin mediates the profibrotic effects of aldosterone in human cardiac fibroblasts (2016) (0)
- High versus low dose losartan and serum potassium: an analysis from HEAAL. (2022) (0)
- Digital health and artificial intelligence in kidney research: a report from the 2020 Kidney Disease Clinical Trialists (KDCT) meeting. (2021) (0)
- Potassium and the use of RAAS inhibitors in Heart Failure 5 with reduced ejection fraction : data from BIOSTAT-CHF 6 (2017) (0)
- High prevalence of sarcopenia in acutely decompensated heart failure (2020) (0)
- HYPERTENSION FOLLOWING RENAL TRAUMA: PREVALENCE, PRESENTATION AND OUTCOME (2004) (0)
- A data science approach for exploring differential expression profiles of genes in transcriptomic studies-Application to the understanding of ageing in obese and lean rats in the FIGHT-HF project (2018) (0)
- Prediction of Long Term Mortality in Patients with Chronic Heart Failure Undergoing Angiotensin Receptor Blockade (2013) (0)
- Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study of the ISARIC cohort (2022) (0)
- [Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: Analysis of French data from the PROKALE multinational European study]. (2021) (0)
- Ventricular–arterial coupling (VAC) in a population-based cohort of middle-aged individuals: The STANISLAS cohort (2023) (0)
- MRI AORTIC THORACIC ELASTIC PROPERTIES ASSESSMENT COMPARED TO ARTERIAL STIFFNESS ASSESSMENT BY TRANSCUTANEOUS DEVICES (2009) (0)
- Low cardiac fibrosis biomarkers levels predict cardiac resynchronization therapy response (2018) (0)
- [Current status of persistent chronic hyperkalaemia in France: An expert consensus based on a Delphi approach]. (2022) (0)
- Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER – Authors' reply (2020) (0)
- HOW GOOD ARE PHYSICIANS AT MEASURING BLOOD PRESSURE IN DIALYSIS? - PATIENT VERSUS PHYSICIAN VIEW (2019) (0)
- BLOOD PRESSURE OUTCOME FOLLOWING ACUTE SEGMENTAL RENAL INFARCTION: P1.210 (2004) (0)
- P6392Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction (2018) (0)
- Regulation and actions of cardiotrophin-1 in cultured rat vascular smooth muscle cells (2008) (0)
- Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalemia: primum non nocere! (2023) (0)
- Supplementary Material for: High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (0)
- Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation (2023) (0)
- 0330 : Fixed ranking of leukocyte telomere length in elderly people: results from 8 year follow-up of the ADELAHYDE cohort (2015) (0)
- Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure (2021) (0)
- The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial (2021) (0)
- Abstract P071: Mineralocorticoid Receptor Overexpression in Adipose Tissue Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase PTGDS and lipocalin-2 NGAL (2015) (0)
- PATIROMER VS PLACEBO TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CKD: ANALYSIS ACCORDING TO PATIENT SEX (AMBER TRIAL) (2021) (0)
- NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients (2022) (0)
- Measurement Methodology: What Does Blood Pressure Mean in the PARTAGE Study?-Reply. (2015) (0)
- O4.07: Low SBP levels under combination anti-hypertensive therapy are associated with increased mortality in elderly subjects living in nursing homes. The PARTAGE study (2014) (0)
- Patrick Rossignol and Faiez Zannad Nephrology Meets Cardiology but East Does Not Meet West Regional Differences in Heart Failure With Preserved Ejection Fraction Trials : When (0)
- PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis (2016) (0)
- Department of Error (2020) (0)
- A randomized controlled multicenter trial of a heparin-grafted membrane for no-heparin hemodialysis versus standard-of-care: results of the HepZero study. (2014) (0)
- 0253: Sympathetic overactivity: a very early manifestation of metabolic syndrome (2014) (0)
- Cardiotrophin-1 induces structural and mechanical changes in aorta (2011) (0)
- FP102EFFECT OF PATIROMER ON SERUM POTASSIUM IN HYPERKALAEMIC PATIENTS WITH AND WITHOUT OBESITY: POOLED RESULTS FROM THE AMETHYST-DN, OPAL-HK AND TOURMALINE TRIALS (2018) (0)
- 100 Renin: A new therapeutic target in the prevention of cardiac remodeling in patients with abdominal obesity? (2012) (0)
- Full Reviews The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients (2017) (0)
- I004 Cardiotrophin-1 actions in vascular smooth muscle cells. A role in arterial stiffness (2009) (0)
- Managing persistent hyperkalaemia with next-generation potassium binders (2022) (0)
- Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort (2021) (0)
- Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from ‘real‐world’ evidence? (2023) (0)
- [Management of atherosclerotic renal artery stenoses]. (2002) (0)
- Heart failure with reduced ejection fraction. Hyperkalemia and worsening renal function as challenges to implementation (guidelines vs real-world). (2016) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- P-053: Telomere attrition during old age can’t explain the relation between short telomere and atherosclerosis (2015) (0)
- Hypo‐ and hyperkalaemia in heart failure. Navigating between Scylla and Charybdis (2020) (0)
- 0470: Role of Lipocalin 2 (LCN2) in cardiovascular remodeling induced by aldosterone (2014) (0)
- Abstract 69: Role of Neutrophil Gelatinase Associated Lipocalin in Cardiovascular Remodeling Induced by Aldosterone (2013) (0)
- Low fibrosis biomarker levels predict cardiac resynchronization therapy response (2019) (0)
- COMPARISON BETWEEN PULSE WAVE VELOCITY ASSESSMENT IN THE OBESE BY TRANSCUTANEOUS DEVICES COMPARED TO PHASE CONTRAST MAGNETIC RESONANCE IMAGING (2009) (0)
- MON-114 Effect of Selective Mineralocorticoid Receptor Antagonist on liver Fat and Metabolism in Patients with Type 2 Diabetes: A Randomized Controlled Trail (2019) (0)
- Vascular smooth muscle cell apoptosis in atherosclerotic plaques is mediated by plasminogen activation (2004) (0)
- Proteolysis and anti-proteolysis in aneurysmal aortic disease (2001) (0)
- Hyperkalemia in the emergency department: Consider the use of nebulized salbutamol. (2019) (0)
- P148: Fixed ranking of leukocyte telomere length in elderly people: Preliminary results from 8 year follow-up of the ADELAHYDE cohort (2014) (0)
- Quel est l’impact des diurétiques de l’anse au long cours dans l’insuffisance cardiaque post-infarctus du myocarde ? Aperçu à partir de l’essai Ephesus (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) (2011) (0)
- A ROLE FOR CARDIOTROPHIN-1 IN MYOCARDIAL FIBROSIS AND LEFT VENTRICULAR DYSFUNCTION: PP.22.346 (2010) (0)
- GALECTIN-3 IS A POTENTIAL MEDIATOR OF ALDOSTERONE EFFECTS IN VASCULAR REMODELING: PP.25.287 (2011) (0)
- Urinary Proteomic Signature of Mineralocorticoid Receptor Antagonism by Spironolactone: Evidence from the Randomized-Controlled HOMAGE and PRIORITY Trials (2023) (0)
- Do not analyze too quickly a result: how spironolactone is always point at! (2015) (0)
- 2725 – HIGH FAT CHOLESTEROL DIET EFFECT ON BLOOD PRESSURE AND SERUM CHOLESTEROL LEVEL OF SPONTANEOUS HYPERTENSIVE RATS (1978) (0)
- Associations of childhood adiposity with adult intima–media thickness and inflammation: a 20-year longitudinal population-based cohort (2022) (0)
- Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial (2022) (0)
- [OP.8A.02] SHORT TELOMERES, BUT NOT TELOMERE ATTRITION RATES, ARE ASSOCIATED WITH CAROTID ATHEROSCLEROSIS (2017) (0)
- Age-dependent telomere attrition, short telomeres and atherosclerosis (2016) (0)
- Sex differences in circulating proteins in heart failure with preserved ejection fraction (2020) (0)
- A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial. (2023) (0)
- [Methodology of clinical research]. (2008) (0)
- FP364THE DILEMMA OF RECURRENT HYPERKALAEMIA MANAGEMENT AND USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS: A EUROPEAN MULTI-NATIONAL TARGETED CHART REVIEW (2018) (0)
- Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19 (2023) (0)
- Extracting Meaning of Tubular Injury Molecules: Implications for Cardiorenal Health (2019) (0)
- NON-ADHERENCE TO ANTIHYPERTENSIVE TREATMENT IS A MAJOR DETERMINANT OF THE CLINIC-AMBULATORY BP DIFFERENCE IN PATIENTS WITH RESISTANT HYPERTENSION (2018) (0)
- IS ANTIHYPERTENSIVE TREATMENT ADAPTATION FROM HOME BLOOD PRESSURE MEASUREMENT OPTIMAL? A PILOT STUDY IN GENERAL PRACTICE: PP.4.107 (2011) (0)
- Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures. (2023) (0)
- Correction to: Prognostic value of estimated plasma volume in acute heart failure in three cohort studies (2018) (0)
- ALPHA 1-ANTITRYPSIN ASSOCIATED WITH HDL INHIBITS ANOIKIS OF VASCULAR CELLS: A NEW ANTI-ATHEROGENIC PROPERTY FOR HDL (2008) (0)
- CARDIOTROPHIN-1 IS A DETERMINANT OF ARTERIAL STIFFNESS AND THICKNESS IN RODENTS: 3A.03 (2010) (0)
- Response to Letter by Hnid (2009) (0)
- Optimization of medical treatment improve long term survival of heart failure patients after ICD and CRT implantation. Insight from National French Database (2018) (0)
- Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial (2021) (0)
- Inductive database to support iterative data mining: Application to biomarker analysis on patient data in the Fight-HF project (2022) (0)
- Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs. (2022) (0)
- Renin–angiotensin system and neprilysin (2018) (0)
- Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease. (2023) (0)
- SO033PATIROMER TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CHRONIC KIDNEY DISEASE (AMBER): PRESPECIFIED RESULTS BY BASELINE SERUM POTASSIUM (2020) (0)
- Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction (2022) (0)
- Impact of timing of randomization after an acute coronary syndrome and subsequent events in patients with type 2 diabetes mellitus: an analysis of the EXAMINE trial (2020) (0)
- SAT-019 ACEi/ARBs, β-blockers or Both in incident End-Stage Renal Disease patients without Cardiovascular Disease: A Propensity-Matched longitudinal study in a Nationwide cohort (2019) (0)
- P4.08: BIOMECHANICAL STUDY OF ANEURYSM RUPTURE (0)
- Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal risk (2021) (0)
- NEW DIALYSIS TECHNIQUES (2014) (0)
- Abstract 17026: Serum Potassium and Outcomes in Heart Failure: Benefit of Aldosterone Antagonists Independent of Baseline Serum Potassium Levels (2010) (0)
- Genetics of severe hypercholesterolemia in the general population: Insights from the STANISLAS cohort (2021) (0)
- [Should angioplasty still be considered for atherosclerotic renal artery stenosis?]. (2001) (0)
- High Blood Pressure and the Risk of Stroke (2006) (0)
- Novel Therapeutic Concepts Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction : integrating evidence into clinical practice (2012) (0)
- H035 Eplerenone survival benefits in heart failure patients post myocardial infarction are independent from its diuretic and potassium-sparing properties: insight from the ephesus data (2009) (0)
- IN 2009, THE FRENCH GP MORE OFTEN PRACTICE HOME-BLOOD PRESSURE MEASUREMENTS THAN IN 2004, WITHOUT FULL COMPLIANCE WITH THE RECOMMENDED METHODOLOGY: 4A.06 (2010) (0)
- Update on Hypertension Management 2018 , 19 , nr . 67 ENDOTHELIAL FACTORS IN THE PATHOGENESIS AND TREATMENT OF CHRONIC KIDNEY DISEASE (2018) (0)
- Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review (2022) (0)
- Wednesday, 29 August 2012 (2012) (0)
- 1054-P: Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Diabetes (2020) (0)
- PowerPoint Slides for: High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (0)
- Comparison Between Central and Peripheral Pulse Pressure as Determinants of Intermediate Cardiovascular Phenotypes (2011) (0)
- [PP.08.06] IS THE DEVELOPMENT OF TELEMEDICINE IN HYPERTENSION A DIGITAL IMMIGRANT ISSUE ? (2016) (0)
- P076: Analysis of MRI-DTI diffusion values as an alternative to the Fazekas score (2014) (0)
- Eplerenone versus placebo renal function stratified dose comparisons in the EMPHASIS-HF trial (2019) (0)
- PP.20.09: NONDIPPING PATTERN AND VASCULAR DAMAGE IN A POPULATION BASED STUDY. THE STANISLAS COHORT STUDY (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Patrick Rossignol?
Patrick Rossignol is affiliated with the following schools:
